A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 5,818 shares of CRL stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,818
Previous 5,677 2.48%
Holding current value
$1.08 Million
Previous $1.17 Million 2.22%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$187.96 - $245.29 $26,502 - $34,585
141 Added 2.48%
5,818 $1.15 Million
Q2 2024

Jul 30, 2024

BUY
$206.39 - $268.73 $286,056 - $372,459
1,386 Added 32.3%
5,677 $1.17 Million
Q1 2024

May 02, 2024

BUY
$203.52 - $273.43 $9,361 - $12,577
46 Added 1.08%
4,291 $1.16 Million
Q3 2023

Oct 30, 2023

BUY
$194.44 - $217.61 $15,360 - $17,191
79 Added 1.9%
4,245 $831,000
Q2 2023

Aug 04, 2023

BUY
$183.71 - $210.25 $4,776 - $5,466
26 Added 0.63%
4,166 $875,000
Q1 2023

May 02, 2023

BUY
$191.89 - $259.92 $9,594 - $12,996
50 Added 1.22%
4,140 $835,000
Q4 2022

Jan 26, 2023

BUY
$197.11 - $250.07 $9,461 - $12,003
48 Added 1.19%
4,090 $0
Q3 2022

Oct 19, 2022

BUY
$182.44 - $250.54 $168,027 - $230,747
921 Added 29.51%
4,042 $795,000
Q2 2022

Jul 13, 2022

BUY
$204.13 - $302.4 $10,206 - $15,119
50 Added 1.63%
3,121 $668,000
Q1 2022

Apr 19, 2022

SELL
$255.51 - $362.11 $117,790 - $166,932
-461 Reduced 13.05%
3,071 $872,000
Q4 2021

Jan 20, 2022

BUY
$351.38 - $448.68 $163,391 - $208,636
465 Added 15.16%
3,532 $1.33 Million
Q3 2021

Oct 15, 2021

SELL
$372.64 - $458.3 $7,452 - $9,166
-20 Reduced 0.65%
3,067 $1.27 Million
Q2 2021

Jul 19, 2021

BUY
$294.17 - $371.65 $908,102 - $1.15 Million
3,087 New
3,087 $1.14 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.